Selecta Biosciences
(NASDAQ) SELB
This security has been delisted. This page is retained for historical reference.
SELB News
3 Top Healthcare Stocks Under $5
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowSELB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
-47%
Return on Equity
3%
Return on Capital
0%
Return on Assets
-44%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$73.94M
Capital Expenditure
$5.45M
Free Cash Flow
$79.39M
Cash & ST Invst.
$125.14M
Total Debt
$12.68M
Selecta Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$947.00K
-95.5%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
64
N/A
Net Income
$92.58M
-195.9%
EBITDA
$21.81M
+154.4%
Quarterly Fundamentals
Net Cash
$112.46M
-43.4%
Accounts Receivable
$1.11M
+27.9%
Inventory
$0.00
N/A
Long Term Debt
$8.53M
-23.4%
Short Term Debt
$4.15M
+45.6%
Return on Assets
-43.96%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$18.20M
-283.2%
Operating Cash Flow
$17.71M
-521.6%